Clinical Trial Update: Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients

View source ↗

Summary

This clinical trial update reports on hepatitis B reactivation risk in lymphoma patients after withdrawal of prophylactic antiviral therapy, highlighting safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Lymphoma

Snippet

Sponsor: Peking University | Conditions: Hepatitis, Hepatitis B | Status: COMPLETED